Top 50 Medical Startup Investors in Italy (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
14 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $483k–$23M |
|
Italian Angels for Growth
VC Fund
|
8 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Panakes Partners
VC Fund
|
6 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.4M–$110M |
|
Innogest Capital
VC Fund
|
6 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
LIFTT
VC Fund
|
5 | Italy, United Kingdom, France | Seed, Series A, Venture - Series Unknown | Biotechnology, Software, Manufacturing | $255k–$118M |
|
Invitalia Ventures
VC Fund
|
4 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, B2B | $658k–$6.2M |
|
Indaco Venture Partners
VC Fund
|
3 | Italy, United Kingdom, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Life Science | $3.3M–$110M |
|
Vertis
VC Fund
|
3 | Italy, United States, United Kingdom | Seed, Series A | Software, Health Care, Biotechnology | $823k–$11M |
|
INGENIUM Emilia Romagna
VC Fund
|
3 | Italy | Seed, Angel | Medical, Health Care, Privacy | $2.1M–$2.2M |
|
Scientifica Venture Capital
VC Fund
|
3 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $209k–$2.9M |
|
Lazio Innova
VC Fund
|
3 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Health Care, Software, Biotechnology | $22k–$1.9M |
|
Lumen Ventures
VC Fund
|
2 | Italy, United States | Seed, Series A, Pre-Seed | Health Care, Medical, Software | $1.4M–$14M |
|
3B Future Health Fund
VC Fund
|
2 | United States, Italy, United Kingdom | Series B, Series A | Biotechnology, Therapeutics, Medical | $2.7M–$75M |
|
Opes Italia
VC Fund
|
2 | Italy, Spain | Venture - Series Unknown, Series A, Seed | E-Commerce, Leisure, Medical | $440k–$7.5M |
|
Neva SGR
VC Fund
|
2 | Italy, United States, Israel | Series B, Series A, Series C | Software, FinTech, Information Technology | $6M–$141M |
|
Sefea Impact
VC Fund
|
2 | Italy | Venture - Series Unknown, Seed, Series A | Medical, Health Care, Information Services | $777k–$5.9M |
|
Antin Infrastructure Partners
VC Fund
|
2 | United States, Italy, United Kingdom | Private Equity, Seed | Energy, Renewable Energy, Commercial | $108M–$1B |
|
Alchimia Investments
VC Fund
|
2 | Italy, United Kingdom, Israel | Series A, Seed, Venture - Series Unknown | Software, Health Care, Medical | $2.2M–$40M |
|
Equiter
VC Fund
|
2 | Italy | Seed, Series B | Medical, Health Care, Information Technology | $2.2M–$4M |
|
The Techshop
VC Fund
|
2 | Italy, Portugal, United Kingdom | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, FinTech | $322k–$120M |
|
P101
VC Fund
|
2 | Italy, Spain, United States | Seed, Series A | Software, E-Commerce, Information Technology | $236k–$15M |
|
Principia SGR
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
Luca Trevisan
Angel
|
2 | Italy | Series A | Medical, Health Care, Medical Device | $750k–$1.4M |
|
ENEA Tech e Biomedical
VC Fund
|
2 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
Fin Posillipo Spa
VC Fund
|
2 | Italy | Seed, Venture - Series Unknown | Medical, Wellness, Health Care | |
|
CDP Equity
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A | SaaS, Elder Care, Small and Medium Businesses | |
|
Sistema Investimenti
VC Fund
|
1 | Italy | Seed | Mobile, Medical, Health Care | $500k–$2.1M |
|
50 Partners Health
VC Fund
|
1 | ||||
|
SIMEST
VC Fund
|
1 | Italy | Grant, Series A, Series B | Manufacturing, Coffee, Aerospace | |
|
Fincarl
VC Fund
|
1 | Italy | Seed | Medical, Health Care | |
|
V-Bio Ventures
VC Fund
|
1 | Belgium, France, United States | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $3.2M–$88M |
|
Maia Ventures
VC Fund
|
1 | Italy | Series A | Medical, Software, Health Care | |
|
Riello Investimenti Partners
VC Fund
|
1 | Italy | Seed | E-Commerce, Food Delivery, Food and Beverage | |
|
Giovanni Cerutti
Angel
|
1 | Italy | Medical, Wellness, Health Care | ||
|
RedSeed Ventures
VC Fund
|
1 | Italy, Israel, United States | Seed, Series A, Series B | Software, Information Technology, Retail | $669k–$16M |
|
Barbara Castellano
Angel
|
1 | Italy, Switzerland | Series A, Series B, Seed | Health Care, Medical Device, Medical | $7.7M–$16M |
|
Andera Partners
VC Fund
|
1 | France, United States, Germany | Series B, Private Equity, Series A | Biotechnology, Health Care, Medical | $7M–$237M |
|
a|impact
VC Fund
|
1 | Italy | Seed, Venture - Series Unknown, Series A | Health Care, Fashion, Wellness | $380k–$3.3M |
|
Rearden Capital Management LLC
VC Fund
|
1 | Italy | Venture - Series Unknown | Medical, Health Care, Biotechnology | |
|
Spindial Group
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
Green Arrow Capital
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A | Health Care, Biotechnology, Manufacturing | $1.5M–$2.2M |
|
Kairos Partners
VC Fund
|
1 | Italy | Seed, Series A | FinTech, Financial Services, Fashion | $2M–$11M |
|
VI Partners
VC Fund
|
1 | Switzerland, Germany, United States | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.3M–$41M |
|
Seroba Life Sciences
VC Fund
|
1 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $4.6M–$105M |
|
Claris Ventures
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Therapeutics | $2.2M–$25M |
|
ArchiMed
VC Fund
|
1 | Italy, Canada, France | Private Equity | Health Care, Manufacturing, Pharmaceutical | |
|
MVM Life Science Partners
VC Fund
|
1 | United States, United Kingdom, Switzerland | Series B, Series C | Health Care, Biotechnology, Medical | |
|
MPM Capital
VC Fund
|
1 | United States, Canada, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | |
|
Index Ventures
VC Fund
|
1 | United States, United Kingdom, France | Series A, Series B, Seed | Software, E-Commerce, Internet | |
|
Rancilio Cube
VC Fund
|
1 | United States, Italy, Germany | Seed, Series A, Series B | E-Commerce, Software, Financial Services | |
| Access all 178 investors in Italy Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 295
- Round size: Seed $483k–$7.7M; Series A $3.3M–$23M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- Mopso — Discover Mopso's anti money laundering detection system. Visit our website and try a 30 minutes free demo with one of our experts.
- ALLSIDES — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 105
- Round size: Seed $329k–$5.1M; Angel $219k–$987k; Series A $3M–$14M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Cato AI — Search, analyze and bid on Italian public tenders with AI, automating the manual work for bid offices and sales teams.
- AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
- Alomana — Autonomous systems for enterprise
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $4.4M–$79M; Series B $10M–$60M; Series C $18M–$110M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
- Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Biotechnology, Software, Manufacturing
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Seed $255k–$7.6M; Series A $2.8M–$21M; Venture - Series Unknown $495k–$118M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, B2B
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — BigProfiles is an Artificial Intelligence Platform designed for Utilities, Telcos, Banks, Insurance companies and Retails.Large companies such as Teleperformance, Eni, Unicef already have already successfully subscribed to our services.BigProfiles is the No-Code Artificial Intelligence Platform for sales and antichurn that predicts thelikelihood to purchase and churn of each customer in a CRM, before proceeding to contact him in a sales or retention campaign.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Series C
- Geography: Italy, United Kingdom, Switzerland
Investor stats
- Total investments: 47
- Round size: Series A $3.3M–$31M; Series B $8.8M–$89M; Series C $16M–$110M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Capitali e competenze per accelerare l'innovazione. Attraverso fondi di investimento chiusi investiamo in startup, scaleup e PMI innovative
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 70
- Round size: Seed $823k–$4M; Series A $1.5M–$11M
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Scuter — Scuter is the smart e-scooter sharing service that makes city mobility,simple, enjoyable and sustainable. Scuter is on well on its path toward making a dent in this space.
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Privacy
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2.1M–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 17
- Round size: Seed $209k–$2.9M; Pre-Seed $209k–$541k
- Lead/follow: 76% lead, 24% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $400k–$1.9M; Grant $22k–$121k; Pre-Seed $53k–$518k
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- HEU — HEU is a legaltech company that automates and manages legal documents and allows users to edit and share them.
- Tech4All — We support the study by using AI.
- GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, United States
Investor stats
- Total investments: 11
- Round size: Seed $1.4M–$5.3M; Series A $5.3M–$14M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $29M in 2020
Portfolio highlights
- qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
- Serenis Health — Serenis Health provides video-based psychotherapy, coaching, and psychological support courses. It believes that the internet is critical to increasing access to mental health care. It makes use of data and digital tools to improve the efficacy of therapies. But, unlike other platforms, it is also a medical center, which means it is responsible forcourse quality and must meet the same standards as any polyclinic.
- AutoConnexa — Scopri AutoConnexa, l'assicurazione online per la tua auto che premia lo stile di guida. Con Drive Connexa, meglio guidi e meno paghi.
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series B, Series A
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 36
- Round size: Series A $2.7M–$41M; Series B $7.4M–$75M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Opes Italia Sicaf Euveca is an impact investing Venture Capital fund. Our aim is to invest in companies based in Italy, or with prevalent activity in the country, and that propose solutions that generate a strong social impact and create positive externalities for the community and the territory.
Show more...Investment focus
- Industry: E-Commerce, Leisure, Medical
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Italy, Spain
Investor stats
- Total investments: 13
- Round size: Seed $440k–$536k; Series A $2.3M–$7.5M; Venture - Series Unknown $2.2M–$4.9M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Baluwo — Toda la ayuda para tu familia en una sola App
- Freedome — Freedome is the leading marketplace for outdoor activities in Italy
- GenomeUp — Rome-based healthtech startup that offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases. GenomeUp's mission is to be a global reference platform to support clinical decision-making for hospitals, laboratories, research centers, and pharmaceuticals to accelerate diagnosis times, improvepatient care and provide knowledge for health prevention, all in less than 24h. Based on these assumptions, the founders decided to evolve the startup and transform it into a Italian Benefit Corporation following the purpose of common benefit by acting responsibly, sustainably and transparently towards stakeholders, people, communities, the territory and the environment.
Neva SGR, part of the Intesa Sanpaolo Group and wholly owned by the Intesa Sanpaolo Innovation Center, plans and manages investment funds for professional investors interested in seizing diversification and high-yield opportunities offered by Venture Capital investments. Neva SGR can count on Intesa Sanpaolo Innovation Center’s and Intesa SanpaoloGroup’s strength, financial resources, know-how and network of relationships, a unique source of value on the market. Neva SGR is the perfect blend of strength, reputation and stability of the Intesa Sanpaolo Group and the best practices of international venture capital firms. Neva SGR aims to boost the Italian economy through new technologies and to be market maker of the VC asset class of venture capital in Italy.
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Series B, Series A, Series C
- Geography: Italy, United States, Israel
Investor stats
- Total investments: 52
- Round size: Series A $6M–$64M; Series B $17M–$141M; Series C $28M–$110M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- iwoca — Iwoca provides financing to businesses for various purposes, including bridging short-term cashflow gaps and investing in stock opportunities. It services retailers, restaurants, hotels, and other businesses. It offers flexible repayment options from 1 day to 24 months, with no penalties for early repayment. Iwoca helps businesses manage cash flowgaps and invest in growth opportunities, enhancing their financial capabilities.
- Straiker — Security for agentic AI applications built from the ground up with fine-tuned models to protect and secure every layer of your agentic AI stack.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Sefea Impact is an asset management company that setting up and managing closed-end alternative investment funds. It aims to generate social impacts through fundamental tools such as tailored finance, technical assistance, and impact measurement.
Show more...Investment focus
- Industry: Medical, Health Care, Information Services
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 8
- Round size: Venture - Series Unknown $777k–$5.9M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
- Planeat.eco — Planeat.eco is the site where you can plan your food shopping in a simple and economical way, starting from the recipes and receiving at home all the ingredients ready for preparation , weighed and divided into compostable containers. They offer their products online.
Antin Infrastructure Partners is a leading private equity firm focused on infrastructure investments.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Commercial
- Stage:Private Equity, Seed
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 16
- Round size: Private Equity $108M–$1B
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.4B in 2023
Portfolio highlights
- CityFibre — CityFibre is a brand new full fibre network built for the data age. Never worry about speed or reliability again. Connect your home and business today.
- Power Dot — Powerdot offers electric vehicle charging solutions in convenient locations across six European countries.
- Origis Energy — Origis Energy is powering the solar revolution with solar power and energy storage projects for utility, corporate and public sector energy clients.
Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and a wide network of international advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Italy, United Kingdom, Israel
Investor stats
- Total investments: 21
- Round size: Seed $2.2M–$11M; Series A $4.4M–$40M; Venture - Series Unknown $5.8M–$14M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- Stellar — At Stellar we bring perfect internet on the move to vehicles and passengers, leveraging the combined strength of cellular, wi-fi, and satellite networks, through AI and fully integrated solutions. We offer SaaS, data plans, and all-inclusive options for enterprise connectivity needs on the move.
Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more...Investment focus
- Industry: Medical, Health Care, Information Technology
- Stage:Seed, Series B
- Geography: Italy
Investor stats
- Total investments: 8
- Round size: Seed $2.2M–$4M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Busforfun — Shared and Green traveling to experience the world of fun#WeTheFun | Busforfun is a young mobility company traveling in a sustainable, safe and low-cost way across Europe. Busforfun vision is a green and shared mobility to experience the world of fun.#WeTheTech | Busforfun is a combination of high tech-startup, e-commerce-platform andtransportation company, Busforfun is going to establish European largest bus network for events in the short time. Thanks to a powerful search engine, business intelligence, an user-friendly booking system and an extensive route network, Busforfun offers travellers the opportunity to experience the world of fun with lower fares.#WeTheGreen | Our low-emission buses comply with the highest safety and environmental standards, so Busforfun offers a sustainable and convenient alternative to cars. With main partner Treedom, Busforfun plants new trees at any travel worldwide.Live Fun Experience in partnership – our concept for successBusforfun provides customers with great offers at lowest budget, through smart network planning, dynamic price management and an adaptive web engine.Busforfun platform is where the innovation and start-up spirit meet the experience and know-how of traditional bus companies and travel agencies.Incredible success can be attributed to the digitalization of old-fashioned bus travel industry: Busforfun has not suppliers or clients: but partners only!
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
The Techshop is a venture capital and private equity firm that invests in B2B digital startups.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Portugal, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $2M–$8.1M; Pre-Seed $322k–$37M; Series A $7.7M–$120M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- CiaoDott — Automatizza le telefonate, prenotazioni e FAQ del tuo studio medico con CiaoDott, l'assistente vocale AI disponibile 24/7. Provalo gratis.
- Octostar — Octostar is the AI-powered investigative intelligence platform for law enforcement, national security, and financial institutions. Connect the dots and discover the facts across petabytes of data.
- Mirai Robotics — Autonomy and intelligence for the seas. We're building software-defined autonomous systems and AI platforms that unify vessels, sensing, and command at sea.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!P101 is an Italian venture capital firm focused on early-stage investments in the digital sector. Agreement to handle personal data I agree I don't agree
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A
- Geography: Italy, Spain, United States
Investor stats
- Total investments: 114
- Round size: Seed $236k–$4.1M; Series A $2.1M–$15M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Cosmico — We are the platform connecting digital talents with the most ambitious companies, using remote work.We have over 8,000 members and our talents have accelerated dozens of projects alongside big names like Accenture Song, Tangity, Frog, Fjord, Sketchin, EY but also aggressive start-ups like Scalapay, Gimme5, Flowe, Unguess.If you are a digitalprofessional: we offer you a community in which to grow your talent through experiences, networks and cosmic projects.If you are a company: we offer you access to a community of designers, developers and marketers from which to select the talents to accelerate your digital transformation projects. Whether you are a manager or a digital professional, Cosmico is here to help you find your space
- A-Cube — A-Cube API: la piattaforma globale per la Tax Compliance. Integra la fatturazione elettronica e gli obblighi fiscali in ogni ERP o e-commerce in Italia e nel mondo.
- Incapto Coffee — Incapto provides coffee solutions that combine specialty whole-bean coffee, super-automatic coffee machines, and subscription-based delivery services for consumers and businesses. The company supplies freshly roasted coffee beans sourced from multiple origins and delivers them directly to customers through recurring subscriptions, ensuringcontinuous availability and freshness. Its offering includes fully automatic coffee machines that grind and brew beans on demand, enabling users to prepare coffee without single-use capsules or manual preparation steps. The company also provides workplace coffee solutions, supplying machines, beans, and technical support for offices, hotels, and food service environments.Incapto integrates digital tools that track consumption, manage inventory, and automate replenishment, allowing customers to monitor usage and receive supplies based on demand. It also offers complementary products such as accessories, beverages, and maintenance services to support ongoing operation of its coffee systems.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-humanstudy on nerve repair that is ongoing at the University of Zurich, Switzerland
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Luca Trevisan Sales Manager and Business Coordinator.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Series A $750k–$1.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
Familiy Office of Petrone Group
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Seed, Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"
Show more...Investment focus
- Industry: SaaS, Elder Care, Small and Medium Businesses
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Neuranix — Neuranix develops, manufactures, and markets innovative devices for the diagnosis of ear diseases in the medical and veterinary fields. They own several patents in the audiological field. They create products based on the analysis of the acoustic characteristics of the eardrum and middle ear measured over a broad spectrum of frequencies. Theysupport the diagnosis and monitor the therapy of middle ear pathologies.
- Rubber Conversion — Rubber Conversion provides recycling, product sustainability, custom packaging, environmental impact analysis, material tracking, and online document management. Their customers contact them through phone, email, and online applications.
Sistema Investimenti is an holding in the form of SpA, established by the will of young professionals and entrepreneurs in Sicily. Sistema Investimenti focus on qualified minorities primarily in companies in the South of Italy with the exception of turnaround/restructuring and distressed.
Show more...Investment focus
- Industry: Mobile, Medical, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Seed $500k–$2.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pedius — Pedius is a communication system that allows deaf people to make normal phone calls. Use it in your everyday life to make important calls such as booking doctors appointments or making reservations, or to call family, friends and coworkers.Once you download the smartphone app you can start a conversation by either typing or speaking a message.The recipient will listen on their end and reply, and you will immediately read a transcription of what he or she just said. Pedius gives you the freedom to have real-time conversations when you need to call a plumber, book a table at your favourite restaurant, or talk to your doctor.The Pedius app is especially useful when you need to contact someone accessible only by phone, and it is an excellent help when you need to be careful about your privacy.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
SIMEST is a financial firm focused on the development and promotion of Italian enterprises abroad. Simest acquires up to 49% of the equity capital of foreign firms in countries outside the European Union, whether wholly-owned by Italian companies or set up as joint ventures with local partners. It also provides start-up and growth capital financingas well as participating in buyouts.Geographically it invests in non-EU countries, focusing on BRIC, Americas and Middle-East. Simest also provides Italian companies seeking to internationalize their businesses with technical assistance and advisory services.Simest is a member of the European Development Finance Institutions (EDFI) and the Italian Venture Capital and Private Equity Association (AIFI).
Show more...Investment focus
- Industry: Manufacturing, Coffee, Aerospace
- Stage:Grant, Series A, Series B
- Geography: Italy
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- hlpy — hlpy operates as a roadside assistance company. Hlpy provides a digital roadside assistance service via a network of 580+ centers, 1,900+ drivers/mechanics, 2,800+ tow trucks.
- Objectway — Powered by over 30 years of business expertise in delivering wealth and asset management technology and services, Objectway empowers its clients to embrace their future challenges while providing great performance today.Objectway solutions and services enable opti-channel customer engagement, front-office productivity, stronger investmentperformance, suitable advice and compliance enforcement, efficient back-office operations and automation, pro-active client reporting and management analytics.Our front-to-back, multi-channel, scalable, cloud-ready platform leverages a component-based architecture with AI-driven algorithmic engines for risk & performance analytics, real-time investment compliance, portfolios optimisation and mass customisation, with open APIs for easy integration.Objectway is a Global Top 100 fintech provider (IDC ranking) and our clients include 200+ leading wealth managers, banks, asset managers, fund managers, insurers and outsourcing providers in more than 15 countries. We support approximately 100,000 investment professionals to manage more than £1 trillion in assets.Objectway operates from offices in Italy, UK, Ireland and Belgium serving customers in 4 continents.
- BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
Fincarl is an investment firm.
Show more...Investment focus
- Industry: Medical, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Lab Evo — Lab Evo is an Italian Digital Healthcare startup that allows customers to manage their health online with direct access to laboratory tests.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Belgium, France, United States
Investor stats
- Total investments: 40
- Round size: Seed $3.2M–$50M; Series A $6.6M–$73M; Series B $12M–$88M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $129M in 2021
Portfolio highlights
- Biodol Therapeutics — Biodol Therapeutics, founded in 2015, develops first-in-class compounds for the treatment of chronic pain (CP). Biodol Therapeutics has identified the Receptor Tyrosine Kinase (RTK) FLT3 as a key player for triggering and maintaining the chronic neuropathic pain (NP) state. New findings from Biodol Therapeutics' academic partnership (CyrilRivat and Jean Valmier at the INSERM Institute for Neurosciences in Montpellier) also demonstrated that FLT3 inhibition increases the potency of opioids for their analgesic effect, and hereby reduces their safety risks, especially addiction risk, which will help fighting the Opioid Crisis. The development of extracellular inhibitors of the FLT3 receptor, is a proprietary and key approach developed by Biodol Therapeutics.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
- Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
Seeding change by investing in category-defining agri & foodtech ventures.
Show more...Investment focus
- Industry: Medical, Software, Health Care
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Biorsaf — Biorsaf is an IT company that develops mobile apps and web control panels to assist companies to bring efficiency to their operations.
- Lembas — Lembas is redefining nutrition for the GLP-1 era. We craft natural, functional foods designed to work with biology - not against it. Our formulations are built for focus, recovery, and longevity, empowering a new generation of eaters to nourish smarter, not more. Explore how Lembas is re-engineering food for a world where better health begins within.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
Riello Investimenti is a private equity investment firm. The firm prefers to invest in Italian small and medium enterprises within the manufacturing, healthcare, energy, media, and logistics sectors. It was founded in 2001 and is based in Milan, Italy.
Show more...Investment focus
- Industry: E-Commerce, Food Delivery, Food and Beverage
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Bevy — Bevy is a startup that brings water, beverages and bulky products to consumers' homes.
- ExoLab Italia — Cosmetics Utilizing plant-derived exosomes in cosmetic products boosts skin absorption, enhancing bioavailability and stimulating cells to produce lacking compounds. Their ability to penetrate the dermis ensures maximum efficacy and optimal results for skincare products. more informations Supplements Plant-derived exosomes, rich in nutrients, enhance bioavailability by
Giovanni Cerutti is a chief executive officer & managing director at NOVAICOS.
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
RedSeed Ventures is a Venture Capital firm investing in Early Stage Companies and Scaleups, in Europe and more particularly in Italy.
Show more...Investment focus
- Industry: Software, Information Technology, Retail
- Stage:Seed, Series A, Series B
- Geography: Italy, Israel, United States
Investor stats
- Total investments: 11
- Round size: Seed $669k–$12M; Series A $2.2M–$16M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Leaf Space — Leaf Space offers a global network of ground stations, providing seamless, cost-effective satellite communication with scalable solutions for all mission sizes.
- Yope — Salo is a discussion platform that erases the borders for people with diverse opinions to let anyone speak up and be heard.
- CyberRidge — CyberRidge is a deep-tech cybersecurity firm that develops photonic encryption to protect data privacy.
Barbara Castellano of Panakes Partners.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B, Seed
- Geography: Italy, Switzerland
Investor stats
- Total investments: 7
- Round size: Series A $7.7M–$16M
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
- Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity, Series A
- Geography: France, United States, Germany
Investor stats
- Total investments: 185
- Round size: Series A $7M–$83M; Series B $14M–$85M; Private Equity $110M–$237M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $466M in 2022
Portfolio highlights
- Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
- Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
- Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.
Show more...Investment focus
- Industry: Health Care, Fashion, Wellness
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Italy
Investor stats
- Total investments: 11
- Round size: Seed $380k–$1.5M; Venture - Series Unknown $418k–$3.3M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Id.Eight — D.EIGHT is a brand of eco-friendly sneakers produced from food industry waste and recycled material.
- AmaliaCare — AmaliaCare is a socially conscious company that gives a new perspective to the world of aged care. AmaliaCare are the premier digital employment agency, specializing in profiling the ideal domestic workers using cutting-edge technology for families seeking dependable assistance for loved ones who are no longer self-sufficient.
- HARG - Healthy Aging Research Group — HARG researches, develops, and markets dehydrated food preparations with modified textures. The company ensures nutritional principles are the same or even enhanced when compared to those of a typical meal by using only natural ingredients. The R&D activity done in collaboration with the University of Genoa ensures scientific efficacy. HARGseeks to enhance the health and wellbeing of those who struggle with swallowing.
Rearden Capital is a trading and investment firm managing proprietary capital across commodity, currency, fixed income and equity asset classes and related derivative instruments in the global markets.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Spindial Group
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 9
- Round size: Series A $1.5M–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
- Maticmind S.p.A — Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators.
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Kairos Partners SGR is a independent Italian asset management company.
Show more...Investment focus
- Industry: FinTech, Financial Services, Fashion
- Stage:Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2M–$11M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Viceversa — Viceversa provides capital to European digital businesses to support companies in sustainable and ethical growth. The company was founded in 2021 and has locations in Milan and Dublin.
- Hercle — Hercle is a regulated digital asset liquidity provider specializing in OTC trading and market making.
- Underscore District — Underscore District unlocks the potential of Made in Italy fashion brands through the power of technology and data analytics.
Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 110
- Round size: Seed $1.3M–$6.5M; Series A $3.7M–$24M; Series B $3.3M–$41M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $117M in 2020
Portfolio highlights
- Altoida — Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),and artificial intelligence (AI).Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.
- SMART VALOR — SMART VALOR is a secure investment platform offering easy buy and sell of cryptocurrencies like Bitcoin, Ethereum, Dash and more. Trade and store digital assets.
- JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 48
- Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $111M in 2017
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Novate Medical — NOvate Medical Technologies is a New Orleans-based medical device development company, focused on commercializing high-quality, low-cost, and sustainable medical products while addressing critical global health needs. NOvate’s first product offering, InfaClip, previously known as SafeSnip, is a patented disposable plastic obstetric device thatsimultaneously cuts, clamps, and shields the infant, mother, and birthing attendant from infection, aimed at reducing maternal and neonatal mortality in developing countries.
- INNOVO by Atlantic Therapeutics — INNOVO is a completely non-invasive, clinically proven and long-lasting solution to urinary incontinence and bladder weakness. See results in 4 weeks!
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Seed, Series A, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 11
- Round size: Seed $2.2M–$11M; Series A $6.1M–$25M; Series B $7.9M–$20M
- Lead/follow: 55% lead, 45% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- ALKemist Bio — ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune system, the company aims to overcome resistance and deliver more effective, lasting treatments for solid tumors.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
ArchiMed is an independent group with funds provided by the team as well as European and American investors, both institutional and private (including a number of successful healthcare entrepreneurs).
Show more...Investment focus
- Industry: Health Care, Manufacturing, Pharmaceutical
- Stage:Private Equity
- Geography: Italy, Canada, France
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Clean Cells — Clean Cells is your reliable CMO/CRO for cell and virus banks manufacturing with a strong expertise in Quality Control Testing for all kind of Bioproducts from R&D to market and in compliance with worldwide regulatory agencies.
- PlasmidFactory — PlasmidFactory is the leading contract manufacturer and service provider for plasmid DNA and minicircle DNA, custom DNA, In-Stock DNA for AAV and clinical application
- Corealis Pharma — Corealis Pharma provides services on a contract basis in the areas of formulation and process development as well as in small-scale clinical trial material manufacturing and the packaging of solid dosage forms to pharmaceutical and biotech companies. Its services include API characterization, salt selection, pre-formulation, formulation and processdevelopment, analytical method development, stability storage, and testing, technical transfer and scale-up, cGMP manufacturing and packaging of phase I and II CTM, and dossier support.
MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 71
- Lead/follow: no public data
Portfolio highlights
- Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
- Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
- Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
Powering Breakthroughs in Life Sciences
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 224
- Lead/follow: no public data
Portfolio highlights
- Syndax Pharmaceuticals — Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor,in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor.Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.
- Portola Pharmaceuticals — As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases.
- Rhythm Pharmaceuticals — Rhythm Pharmaceuticals is a global biopharmaceutical company committed to transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision medicines that address the root cause.
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 1013
- Lead/follow: no public data
Portfolio highlights
- BIT ODD — Gaming company building games filled with wonder, weirdness and delight
- Dream Games — Join Dream Games and explore a vibrant universe of characters and puzzles. Discover why millions of players worldwide love our mobile games. Visit us to learn more about our games, company culture, and career opportunities.
- Acutus Medical — Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists.Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, California. Itsproducts are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.It was founded in 2011 and headquartered in Carlsbad, California.
Cube is the investment office founded by Rancilio family
Show more...Investment focus
- Industry: E-Commerce, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Italy, Germany
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- Convoy — Convoy uses technology to make freight more efficient, reduce shippers' costs, increase carriers' earnings, and eliminate carbon emissions.
- FinCompare - Smarter Business Finance — FinCompare was founded by Stephan Heller and is a fintech startup that helps businesses to find, compare, and close the financing solutions. Via the online platform, companies can access a wide range of financing options. They can independently compare offers from well-known banks, fintechs, and alternative financial services providers in Germanyand close the financing. The company also offers a convenient one-stop destination for all financing questions relating to the company.FinCompare financing solutions including corporate loan, factoring, company leasing/hire purchase, warehouse financing, fine trading/purchase financing, and mezzanine capital. It simplifies the financing process with its digital application process and can thus provide your company financing. The company allows SMEs to receive and compare various offers for loans.FinCompare was founded in October 2016 by Stephan Heller and is headquartered in Berlin, Germany.
- Finom — Finom combines digital business account benefits with multiple services to provide financial solutions for entrepreneurs, self-employed, and freelancers. It pulls together accounting, financial management, and banking functions for early-stage businesses and SMEs into one mobile-first product.Founded in 2019, Finom is headquartered in Amsterdam,The Netherlands.
Medical Investor funding in Italy at a glance
Stats across 130 deals from 178 investors.
Access all 178 investors in Italy Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 178 investors investing in Italy Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!